Physician profile
Kendall Itoku
NPI 1699870162
$2,098.85
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $409 · 2021: $823 · 2022: $34.56 · 2023: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $349.14 | 2019-2021 | |
| Allergan, INC. | $201.68 | 2019-2021 | |
| Boston Scientific Corporation | $189.60 | 2019-2021 | |
| Genzyme Corporation | $149.99 | 2023 | |
| Janssen Biotech, INC. | $140.00 | 2019-2021 | |
| Antares Pharma, INC. | $103.25 | 2019-2021 | |
| Pfizer INC. | $100.92 | 2019-2020 | |
| Blue Earth Diagnostics | $84.13 | 2021 | |
| Myriad Genetic Laboratories, INC. | $75.79 | 2021 | |
| Convatec INC. | $70.74 | 2020-2021 | |
| Travere Therapeutics, INC. | $63.56 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $62.92 | 2020-2021 | |
| Karl Storz Endoscopy-America | $62.50 | 2019 | |
| Neotract INC. | $55.79 | 2019-2020 | |
| Abbvie INC. | $52.53 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $45.80 | 2021 | |
| Amgen INC. | $43.57 | 2019-2020 | |
| Urovant Sciences INC | $39.75 | 2021 | |
| Laborie Medical Technologies Corp. | $32.45 | 2020-2022 | |
| Clarus Therapeutics INC. | $32.29 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $24.50 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $17.53 | 2020 | |
| Cook Medical LLC | $16.24 | 2019 | |
| Myovant Sciences INC. | $15.79 | 2021 | |
| 180 Medical, INC. | $14.98 | 2020 | |
| Rochester Medical Corporation | $14.03 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.80 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $13.52 | 2019 | |
| Metuchen Pharmaceuticals | $12.06 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendall Itoku listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.